Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Cytogenetic damage of lymphocytes studied in patients receiving cancer therapy
February 23rd, 2006
Cytogenetic damage in lymphocytes was studied in patients receiving therapy for small cell lung cancer and ovarian carcinoma. According to recent research published in the journal Toxicology and Applied Pharmacology, "The level of cytogenetic damage in peripheral blood lymphocytes of patients undergoing chemotherapy has been analyzed incisively 20 years ago. The results showed that the highest level of cytogenetic damage was observed at the end of therapy." "In recent years, the doses of anticancer drugs were intensified thanks to the discovery of colony stimulating factors. Therefore, it was interesting to analyze the kinetics of micronuclei...
Source: Women's Health Weekly (2006-02-23)
|
